BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 17402955)

  • 21. Working patterns and perceived contribution of prostate cancer clinical nurse specialists: a mixed method investigation.
    Ream E; Wilson-Barnett J; Faithfull S; Fincham L; Khoo V; Richardson A
    Int J Nurs Stud; 2009 Oct; 46(10):1345-54. PubMed ID: 19358991
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Uncertainty after treatment for prostate cancer: definition, assessment, and management.
    Yu Ko WF; Degner LF
    Clin J Oncol Nurs; 2008 Oct; 12(5):749-55. PubMed ID: 18842531
    [TBL] [Abstract][Full Text] [Related]  

  • 23. The self-management of uncertainty among men undertaking active surveillance for low-risk prostate cancer.
    Oliffe JL; Davison BJ; Pickles T; Mróz L
    Qual Health Res; 2009 Apr; 19(4):432-43. PubMed ID: 19229061
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Decision analyses in consideration of treatment strategies for patients with biochemical failure after curative therapy on clinically localized prostate cancer in the prostate-specific antigen era.
    Shimizu F; Igarashi A; Fukuda T; Kawachi Y; Minowada S; Ohashi Y; Fujime M
    Jpn J Clin Oncol; 2007 Oct; 37(10):763-74. PubMed ID: 17956899
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The 20-Yr outcome in patients with well- or moderately differentiated clinically localized prostate cancer diagnosed in the pre-PSA era: the prognostic value of tumour ploidy and comorbidity.
    Adolfsson J; Tribukait B; Levitt S
    Eur Urol; 2007 Oct; 52(4):1028-35. PubMed ID: 17467883
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Geographic and socioeconomic variation in the treatment of prostate cancer.
    Krupski TL; Kwan L; Afifi AA; Litwin MS
    J Clin Oncol; 2005 Nov; 23(31):7881-8. PubMed ID: 16204005
    [TBL] [Abstract][Full Text] [Related]  

  • 27. An Internet intervention for management of uncertainty during active surveillance for prostate cancer.
    Kazer MW; Bailey DE; Sanda M; Colberg J; Kelly WK
    Oncol Nurs Forum; 2011 Sep; 38(5):561-8. PubMed ID: 21875843
    [TBL] [Abstract][Full Text] [Related]  

  • 28. The needs of men with prostate cancer: results of a focus group study.
    Wallace M; Storms S
    Appl Nurs Res; 2007 Nov; 20(4):181-7. PubMed ID: 17996804
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Age, health, and education determine supportive care needs of men younger than 70 years with prostate cancer.
    Smith DP; Supramaniam R; King MT; Ward J; Berry M; Armstrong BK
    J Clin Oncol; 2007 Jun; 25(18):2560-6. PubMed ID: 17577034
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Focal therapy for localized prostate cancer: a critical appraisal of rationale and modalities.
    Eggener SE; Scardino PT; Carroll PR; Zelefsky MJ; Sartor O; Hricak H; Wheeler TM; Fine SW; Trachtenberg J; Rubin MA; Ohori M; Kuroiwa K; Rossignol M; Abenhaim L;
    J Urol; 2007 Dec; 178(6):2260-7. PubMed ID: 17936815
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Uncertainty and quality of life of older men who undergo watchful waiting for prostate cancer.
    Wallace M
    Oncol Nurs Forum; 2003; 30(2):303-9. PubMed ID: 12692664
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Watchful waiting for prostate cancer: a review article.
    Chodak GW; Warren KS
    Prostate Cancer Prostatic Dis; 2006; 9(1):25-9. PubMed ID: 16402090
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Prostate cancer outcomes among older men: insurance status comparisons results from CaPSURE database.
    Sadetsky N; Elkin EP; Latini DM; DuChane J; Carroll PR;
    Prostate Cancer Prostatic Dis; 2008; 11(3):280-7. PubMed ID: 17893700
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Predictors for the symptomatic prostate cancer patient's delays in seeking care.
    Sunny L; Hopfgarten T; Adolfsson J; Steineck G
    Eur J Cancer; 2008 Mar; 44(5):733-9. PubMed ID: 18289844
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Conventional treatments of localized prostate cancer.
    Zerbib M; Zelefsky MJ; Higano CS; Carroll PR
    Urology; 2008 Dec; 72(6 Suppl):S25-35. PubMed ID: 19095125
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Pathological characteristics of prostate cancer in elderly men.
    Delongchamps NB; Wang CY; Chandan V; Jones RF; Threatte G; Jumbelic M; de la Roza G; Haas GP
    J Urol; 2009 Sep; 182(3):927-30. PubMed ID: 19616228
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Prostate cancer disease-free survival after radical retropubic prostatectomy in patients older than 70 years compared to younger cohorts.
    Malaeb BS; Rashid HH; Lotan Y; Khoddami SM; Shariat SF; Sagalowsky AI; McConnell JD; Roehrborn CG; Koeneman KS
    Urol Oncol; 2007; 25(4):291-7. PubMed ID: 17628294
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Analysis linking UCLA PCI with Expanded Prostate Cancer Index Composite: an evaluation of health related quality of life in Japanese men with localized prostate cancer.
    Namiki S; Takegami M; Kakehi Y; Suzukamo Y; Fukuhara S; Arai Y
    J Urol; 2007 Aug; 178(2):473-7; discussion 477. PubMed ID: 17561164
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Patient treatment preferences in localized prostate carcinoma: The influence of emotion, misconception, and anecdote.
    Denberg TD; Melhado TV; Steiner JF
    Cancer; 2006 Aug; 107(3):620-30. PubMed ID: 16802287
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Patterns of primary and secondary therapy for prostate cancer in elderly men: analysis of data from CaPSURE.
    Konety BR; Cowan JE; Carroll PR;
    J Urol; 2008 May; 179(5):1797-803; discussion 1803. PubMed ID: 18343440
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 13.